Endurance28

Endurance28 is an early-stage venture capital firm investing in ambitious startups tackling major challenges in climate, health & well-being, and digital economy. Its health investments include therapeutics for chronic diseases like diabetes and obesity as well as novel diagnostic platforms. The company does not itself conduct clinical trials but backs startups at preclinical through early clinical stages.

Example results from its portfolio:

• Encellin develops thin-film cell encapsulation devices for cell-based therapeutics targeting Type 1 diabetes.
• Equator Therapeutics develops small molecules aimed at increasing energy expenditure for weight loss without muscle loss.

Clinical results are specific to each portfolio company rather than Endurance28 itself.